NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial
PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency).
Pharmabiz7h
ProMIS Neurosciences begins patient dosing in phase 1b PRECISE-AD trial of PMN310 for Alzheimer’s disease
Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...
Clene Inc. (NASDAQ: CLNN) Leverages APST's Nfl Database To Support FDA-Recommended Analyses For ALS Drug
Clene is partnering with APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8® in ALS p ...
Measles cases in western Texas rise to 146, possibly spreading to other areas
The number of confirmed measles cases in western Texas grew to 146, and it is possibly spreading to the central part of the ...
Poor sleep endangers health of two-thirds of people in U.S.
About two-thirds of Americans are getting too little or too much sleep, risking their health, a new study suggests.
440 Shares in argenx SE (NASDAQ:ARGX) Bought by Ieq Capital LLC
Ieq Capital LLC bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) during the fourth quarter, according to the ...
I'm recently retired — and was diagnosed with pancreatic cancer. My doctor wants to start chemo ASAP, but I have a gap in my health insurance. What should I do?
But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...
The Canadian Press on MSN12h
Today-History-Mar01
Today in History for March 1: ...
MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com
Analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s ...